A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer

被引：0
|
作者：
Li, Y. [1 ]
Xing, L. [1 ]
Yin, X. [1 ]
Li, H. [1 ]
Ren, G. [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.03.082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68P
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [21] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Feng Ding
    Ru-Yue Chen
    Jun Hou
    Jing Guo
    Tian-Yi Dong
    World Journal of Clinical Cases, 2022, 10 (12) : 3698 - 3708
  • [22] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Ding, Feng
    Chen, Ru-Yue
    Hou, Jun
    Guo, Jing
    Dong, Tian-Yi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3698 - 3708
  • [23] Predictors of response to neoadjuvant checkpoint inhibition with chemotherapy in triple-negative breast cancer (TNBC): A meta-analysis of randomized control trials (RCTs)
    Roy, A. M.
    Attwood, K.
    Gandhi, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S192 - S192
  • [24] Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
    Poggio, F.
    Bruzzone, M.
    Ceppi, M.
    Ponde, N. F.
    La Valle, G.
    Del Mastro, L.
    de Azambuja, E.
    Lambertini, M.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1497 - 1508
  • [25] Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
    Li, Zhen-Yu
    Zhang, Zhen
    Cao, Xiao-Zhong
    Feng, Yun
    Ren, Sha-Sha
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
  • [26] Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
    Xun, Xueqiong
    Cao, Qinguang
    Hong, Pan
    Rai, Saroj
    Zhou, Yeming
    Liu, Ruikang
    Hu, Huiyong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
    Yu, Y.
    Zhang, J.
    Lin, Y.
    Kang, S.
    Lv, X.
    Song, C.
    BREAST, 2021, 56 : S50 - S50
  • [28] Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate
    Poggio, F.
    Tagliamento, M.
    Ceppi, M.
    Bruzzone, M.
    Conte, B.
    Fregatti, P.
    Punie, K.
    de Azambuja, E.
    Del Mastro, L.
    Lambertini, M.
    ANNALS OF ONCOLOGY, 2022, 33 (03) : 347 - 349
  • [29] Efficacy and safety of adding carboplatin in neoadjuvant chemotherapy for triple-negative breast cancer - real-world data
    Leung, K. H.
    Kwok, C. C. H.
    BREAST, 2025, 80
  • [30] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Steiner, Meghan
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
12345